Body Composition Changes and Anabolic Hormone Considerations with Advancing Age and in Persons with Spinal Cord Injury

Wounds

Volumn 13, Issue 4 SUPPL. D, 2001, Pages

  Bauman, William A ^a   Spungen, Ann M ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0035641195     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Steen B. Body composition and aging. Nutr Rev 1988;46:45-51.
2. Forbes GB. Longitudinal changes in adult fat-free mass: Influence of body weight. Am J Clin Nutr 1999;70:1025-31.
3. Evans WJ. What is sarcopenia? J Geontol A Biol Sci Med Sci 1995;50 Spec No:5-8.
4. Novak LP. Aging, total body potassium, fat-free mass, and cell mass in males and females between ages 18 and 85 years. J Gerontol 1972;27:438-13.
5. Cohn SH, Vartsky D, Yasumaura S, et al. Compartmental body composition based on total-body, potassium, and calcium. Am J Physiol 1980;239:E524-30.
6. Melton LJ, Khosla S, Crowson CS, et al. Epidemiology of sarcopenia. J Am Geriatr Soc 2000;48:625-30.
7. Larsson L. Muscle strength and speed of movement in relation to age and muscle morphology. J Appl Physiol 1979;46:451-6.
8. Danneskoild-Samsoe B, Kofod V, Munter J, et al. Muscle strength and functional capacity in 77-81 year old men and women. Eur J Appl Physiol 1984;52:123-35.
9. Larsson L. Histochemical characteristics of human skeletal muscle during aging. Acta Physiol Scand 1983;117:469-71.
10. Klitgaard H, Mantoni M, Schiamffino S, et al. Function, morphology and protein expression of ageing skeletal muscle: A cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand 1990;140:41-54.
11. Fontera WR, Meredith CN, O'Reilly KP, et al. Strength conditioning in older men: Skeletal muscle hypertrophy and improved function. J Appl Physiol 1988;64:1038-44.
12. Fontera WR, Hughes VA, Evans WJ. A cross-sectional study of upper and lower extremity muscle strength in 45-78 year old men and women. J Appl Physiol 1991;71:644-50.
13. Evans WJ. What is sarcopenia? J Gerontology Series A 1995;50A:5-8.
14. Monroe HN. Protein. In: Hartz SC, Russell RM, Rosenberg IH (eds). Nutrition and the Elderly: The Boston Nutritional Status Survey. London, UK: Smith-Gordon & Co Ltd, 1992:75-86.
15. Bhasin S, Storer TW, Berman N, et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997;82:407-13.
16. Mauras N, Hayes V, Welch S, et al. Testosterone deficiency in young men: Marked alterations in whole body protein kinetics, strength, and adiposity. J Clin Endocrinol Metab 1998;83:1886-92.
17. Wang C, Swerdloff RS, Iranmanesh A, et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 2000;85:2839-53.
18. Dudl J, Ensinck JH, Palmer E, et al. Effect of age on growth hormone secretion in man. J Clin Endocrinol Metab 1973;37:11-6.
19. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991;73:1081-8.
20. Corpas E, Harman SM, Blackman MNR. Human growth hormone and human aging. Endocrine Rev 1993;14:20-39.
21. Cuneo RC, Judd S, Wallace JD, et al. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 1998;83:107-16.
22. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1-6.
23. Harman SM, Tsitouras PD. Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin. J Clin Endocrinol Metab 1980;51:35-40.
24. Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Clin Endocrinol Metab 2001;724-31.
25. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massac husetts male aging study. J Clin Endocrinol Metab 1991;73:1016-25.
26. Bhasin S, Storer TR, Berman N, et al. Testosterone Replacement increased fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab 1997;82:407-13.
27. Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992;75:1092-8.
28. Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999;84:2647-53.
29. Ulloa-Aquirre A, Blizzard RM, Garcia-Rubi E, et al. Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life. J Clin Endocrinol Metab 1990;71:846-54.
30. Chatelain PG, Sanchez P, Saez JM. Growth hormone and insulin-like growth factor I treatment increase testicular luteinizing hormone receptors and steroidogenic responsiveness of growth hormone deficient dwarf mice. Endocrinology 1991;128:1857-62.
31. Tsitouras PD, Zhong YG, Spungen AM, Bauman WA. Serum testosterone and insulin-like growth factor-I/growth hormone in adults with spinal cord injury. Horm Met Res 1995;27:287-92.
32. Korenman SG. A pragmatic approach to androgen replacement in older men: Risks vs. benefits. J Clin Endocrinol Metab 1998;83:3441-2.
33. Bauman WA. Carbohydrate and lipid metabolism after spinal cord injury. Topics in Spinal Cord Injury Rehabilitation 1997;2:1-22.
34. Bauman WA, Adkins RH, Spungen AM, et al. The effect of residual neurological deficit on oral glucose tolerance in persons with chronic spinal cord injury. Spinal Cord 1999;37:765-71.
35. Bauman WA, Adkins RH, Spungen AM, et al. Is immobilization associated with an abnormal lipoprotein profile? Observations from a diverse cohort. Spinal Cord 1999;37:485-93.
36. Bauman WA, Spungen AM, Zhong YG, et al. Depressed serum high density lipoprotein cholesterol levels with spinal cord injury. Paraplegia 1992;30:697-703.
37. Bauman WA, Raza M, Machac J. Tomographic thallium201 myocardial perfusion imaging after intravenous dipyridamole in asymptomatic subjects with quadriplegia. Arch Phys Med Rehab 1993;174:740-4.
38. Bauman WA, Raza M, Spungen AM, et al. Cardiac stress testing with thallium-201 imaging reveals silent ischemia in individuals with paraplegia. Arch Phys Med Rehabil 1994;75:946-50.
39. Wilmet E, Ismail AA, Heilporn A, et al. Longitudinal study of bone mineral content and soft tissue composition after spinal cord section. Paraplegia 1996;33:674-7.
40. Rossier AB, Favre H, Valloton MB. Body composition and endocrine profile in spinal cord injured patients. In: Lee BY, Ostrander E, George J, Cochran B, Shaw WW (eds). The Spinal Cord Injured Patient. Comprehensive Management. WB Saunders Co., 1991:163-70.
41. Rasmann Nuhlicek DN, Spurr GB, Barboriak JJ, et al. Body composition of patients with spinal cord injury. Euro J Clin Nutr 1988;42:765-73.
42. Cardus D, McTaggart WG. Body composition in spinal cord injury. Arch Phys Med Rehabil 1985;66:257-9.
43. Shizgal HM, Roza A, Leduc B, et al. Body composition in quadriplegic patients. J Parenteral & Enteral Nutr 1986;10:364-8.
44. Spungen AM, Adkins RH, Bauman WA, et al. The effect of level and completeness of lesion on body composition in subjects with spinal cord injury. J Spinal Cord Med 1999;22:43.
45. Spungen AM, Wang J, Pierson RN Jr, Bauman WA. Soft tissue body composition differences in monozygotic twins discordant for immobilization. J Applied Physiol 2000;88:1310-5.
46. Spungen AM, Bauman WA, Wang J, Pierson RN Jr. The relationship between total body potassium and resting energy expenditure in individuals with paraplegia. Arch Phys Med Rehabil 1993;73:965-8.
47. Mollinger LA, Spurr GB, El Ghatit AZ, et al. Daily energy expenditure and basal metabolic rates of patients with spinal cord injury. Arch Phys Med Rehabil 1985;66:420-6.
48. Wang YH, Huang TS, Lien IN. Hormonal changes in men with spinal cord injuries. Am J Phys Med Rehabil 1992;71:328-32.
49. Bulat T, Tsitouras PD, Drexler H, et al. Hypothalamic-pituitary axis in chronic spinal cord injured subjects. APS, J Spinal Cord Med 1995;18:293.
50. Bauman WA, Spungen AM, Flanagan S, et al. Blunted growth hormone response to intravenous arginine in subjects with a spinal cord injury. Horm Met Res 1994;26:149-53.
51. Shetty K, Sutton CH, Mattson DE, et al. Hyposomatomedinemia in quadriplegic men. Am J Med Sci 1993;305:95-100.
52. Rao U, Shetty KR, Mattson DE, et al. Prevalence of low plasma IGF-I in poliomyelitis survivors. J Am Geriatr Soc 1993;41:697-702.
53. Bauman WA, Spungen AM, Zhong YG, Tsitouras PD. Chronic baclofen therapy improves the blunted growth hormone response to intravenous arginine in subjects with spinal cord injury. J Clin Endocrin Metab 1994;78:1135-8.
54. Demling R, De Santi L. Oxandrolone, anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma 1997;43:47-51.
55. Demling R, De Santi L. Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burns 1999;25:215-21.
56. Spungen AM, Koehler KM, Modeste-Duncan R, Rasul M, Cytryn AS, Bauman WA. Nine clinical cases of nonhealing pressure ulcers in patients with spinal cord injury treated with an anabolic agent: A therapeutic trial. Adv Skin Wound Care 2001;14:139-44.
57. Demling R, De Santi L. Closure of the "non-healing wound" corresponds with correction of weight loss using the anabolic agent oxandrolone. Ost/Wound Manag 1998;44:58-68.
58. Alexander LR, Spungen AM, Liu MH, et al. Resting metabolic rate in subjects with paraplegia: The effect of pressure sores. Arch Phys Rehabil 1995;76:819-22.
59. Liu MH, Spungen AM, Fink L, et al. Increased energy needs in patients with quadriplegia and pressure ulcers. Adv Wound Care 1996;9:41-5.